University of Pecs
pte.huTotal trials
97
Active
18
Phase 3
7
Total enrollment
30,352
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Oral iron supplementation | — | — | — | — | — | 1 | |
| Intravenous iron supplementation | — | — | — | — | — | 1 | |
| alverine-citrate + simethicone and lactase | — | — | — | — | — | 1 | |
| alverin-citrate + simethicone with placebo | — | — | — | — | — | 1 |
Next readouts
- 2026-09
- 2027-12-31
Top conditions
- COVID-195
- Sepsis4
- Physical Inactivity4
- Knee Osteoarthritis4
- Diabetes Mellitus3
- Diabetes Mellitus, Type 23
- Urinary Incontinence3
- Cardiac Arrest (CA)3
Frequently asked questions about University of Pecs
- How many clinical trials does University of Pecs have on ClinicalTrials.gov?
- University of Pecs is listed as the lead sponsor on 97 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Pecs's trials are in Phase 3?
- 7 of University of Pecs's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does University of Pecs focus on?
- University of Pecs's most-studied conditions on ClinicalTrials.gov are COVID-19, Sepsis, Physical Inactivity, Knee Osteoarthritis, Diabetes Mellitus.
- When are University of Pecs's next clinical trial readouts?
- University of Pecs has 2 upcoming primary-completion readouts tracked here; the soonest is “The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)”, expected around 2026-09.